NAAF is proud to announce the recipients of our 2025 Early Career and Research Grant Awards. These investigators are dedicated…
I’m writing this in remembrance of my dear friend and mentor, who we recently lost to Parkinson’s disease. Alan grew…
The National Alopecia Areata Foundation (NAAF) has retained The Alexander Group to recruit its President and Chief Executive Officer. NAAF serves the…
Congratulations to NAAF award recipient Aubrey Martin on her recent publication, “Switching between Janus kinase inhibitors for treatment of alopecia…
NAAF is excited to share a new resource created with and for the alopecia areata community: the Confidence Guide—a practical…
NAAF Community, Since January 2022, I have had the honor of serving as NAAF’s President & CEO. From the very…
A report recently published in the October 2025 issue of JAMA Dermatology suggests that people with alopecia areata may still benefit from trying a different Janus…
Nektar Therapeutics announced today new results from its Phase 2b REZOLVE-AA study testing rezpegaldesleukin (REZPEG)—an experimental immune-modulating drug—in adults with…
Eli Lilly (Lilly) recently shared 52-week results from its Phase 3 clinical trial examining oral baricitinib (Olumiant®) 4 mg for…
